A detailed history of Rothschild Investment LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 135 shares of RLAY stock, worth $641. This represents 0.0% of its overall portfolio holdings.

Number of Shares
135
Previous 60 125.0%
Holding current value
$641
Previous $391,000 144.5%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$6.23 - $9.51 $467 - $713
75 Added 125.0%
135 $956,000
Q2 2024

Jul 30, 2024

BUY
$5.9 - $8.02 $354 - $481
60 New
60 $391,000
Q1 2024

Jul 31, 2024

SELL
$7.5 - $12.07 $337 - $543
-45 Reduced 75.0%
15 $125,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $571M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.